Organon (FRA:7XP) Beginning Cash Position : €624 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Organon Beginning Cash Position?

Organon's Beginning Cash Position for the quarter that ended in Mar. 2025 was €624 Mil.

Organon's quarterly Beginning Cash Position increased from Sep. 2024 (€634 Mil) to Dec. 2024 (€729 Mil) but then declined from Dec. 2024 (€729 Mil) to Mar. 2025 (€624 Mil).

Organon's annual Beginning Cash Position declined from Dec. 2022 (€696 Mil) to Dec. 2023 (€647 Mil) but then increased from Dec. 2023 (€647 Mil) to Dec. 2024 (€662 Mil).

Organon Beginning Cash Position Historical Data

The historical data trend for Organon's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Beginning Cash Position Chart

Organon Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

214.54

61.95

695.73

647.40

661.82

Organon Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Beginning Cash Position	Get a 7-Day Free Trial															637.56	534.18	634.30	728.67	624.38

Organon Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Organon Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Organon's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Organon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (FRA:7XP) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

OGN:USA OGN:Mexico 1OGN:Italy 0A9W:UK 7XP:Germany

Address

30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302

Website

https://www.organon.com

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Organon Headlines

No Headlines